EAST END GROUP, LLC for NOVARTIS
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 17, 2023 | $45,000 | Replaced |
| 4th Quarter - Termination (this page) | Jan 23, 2023 | $45,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General health care coverage and reimbursement for prescription drugs; drug pricing reform, including the 340b Program; and the Food and Drug Administration legislation, include the Prescription Drug User Fee Act Reauthorization (PDUFA), Budget Reconciliation other regulatory issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY CHILDRESS LANGE | Rep. Mike Rogers, LA; Rep. John Shimkus, LA. |
| ANDREW HAWKINS | Rep. Mike Rogers, Chief of Staff, LD, LA. |
| DAVID THOMSON MOHLER | — |
Medicare/Medicaid MMM
General health care coverage and reimbursement for prescription drugs; drug pricing reform, included in Budget Reconciliation other regulatory issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY CHILDRESS LANGE | Rep. John Shimkus, LA; Rep. Mike Rogers, Health Policy Advisor |
| ANDREW HAWKINS | Rep. Mike Rogers, LA, Chief of Staff |
| DAVID THOMSON MOHLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.